Impact of Disease Biology and Bridging Strategy on Outcomes After CAR-T Cell Therapy in Relapsed/Refractory Multiple MyelomaIrene Straßl, Maria‐Theresa Krauth, Nina Worel et al.|Transplantation and Cellular Therapy|2026Cited by 0